574 related articles for article (PubMed ID: 19817893)
1. CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma.
Nishihara Y; Aishima S; Hayashi A; Iguchi T; Fujita N; Taketomi A; Honda H; Tsuneyoshi M
Histopathology; 2009 Oct; 55(4):423-31. PubMed ID: 19817893
[TBL] [Abstract][Full Text] [Related]
2. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).
Schmitz KJ; Lang H; Kaiser G; Wohlschlaeger J; Sotiropoulos GC; Baba HA; Jasani B; Schmid KW
Hum Pathol; 2009 Dec; 40(12):1706-14. PubMed ID: 19683330
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
[TBL] [Abstract][Full Text] [Related]
4. Extrahepatic cholangiocarcinoma: current surgical strategy.
Boutros C; Somasundar P; Espat NJ
Surg Oncol Clin N Am; 2009 Apr; 18(2):269-88, viii. PubMed ID: 19306812
[TBL] [Abstract][Full Text] [Related]
5. Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type.
Aishima S; Kuroda Y; Nishihara Y; Iguchi T; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
Am J Surg Pathol; 2007 Jul; 31(7):1059-67. PubMed ID: 17592273
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic diversity of intrahepatic and extrahepatic cholangiocarcinoma on aspiration cytology and core needle biopsy: case series and review of the literature.
Chaudhary HB; Bhanot P; Logroño R
Cancer; 2005 Aug; 105(4):220-8. PubMed ID: 15952192
[TBL] [Abstract][Full Text] [Related]
7. Left hemihepatectomy and caudate lobectomy and complete extrahepatic bile duct resection using transduodenal approach for hilar cholangiocarcinoma arsing from biliary papillomatosis.
Kim JK; Hwang HK; Park JS; Cho SI; Yoon DS; Chi HS
J Surg Oncol; 2008 Aug; 98(2):139-42. PubMed ID: 18521837
[TBL] [Abstract][Full Text] [Related]
8. Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma.
Nakagohri T; Asano T; Kinoshita H; Kenmochi T; Urashima T; Miura F; Ochiai T
World J Surg; 2003 Mar; 27(3):289-93. PubMed ID: 12607053
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic factors and long term outcome after surgery for hilar cholangiocarcinoma. Univariate and multivariate analysis].
Ramacciato G; Di Benedetto F; Cautero N; Masetti M; Mercantini P; Corigliano N; Nigri G; Lauro A; Ercolani G; Del Gaudio M; De Ruvo N; Pinna AD
Chir Ital; 2004; 56(6):749-59. PubMed ID: 15771027
[TBL] [Abstract][Full Text] [Related]
10. Carcinoma of the extrahepatic bile duct: mode of spread and its prognostic implications.
Yamaguchi K; Chijiiwa K; Saiki S; Shimizu S; Takashima M; Tanaka M
Hepatogastroenterology; 1997; 44(17):1256-61. PubMed ID: 9356836
[TBL] [Abstract][Full Text] [Related]
11. The clinical presentation and prognostic factors for intrahepatic and extrahepatic cholangiocarcinoma in a tertiary care centre.
Singal AG; Rakoski MO; Salgia R; Pelletier S; Welling TH; Fontana RJ; Lok AS; Marrero JA
Aliment Pharmacol Ther; 2010 Mar; 31(6):625-33. PubMed ID: 20003093
[TBL] [Abstract][Full Text] [Related]
12. The current management of hilar cholangiocarcinoma.
Jarnagin WR; Fong Y; Blumgart LH
Adv Surg; 1999; 33():345-73. PubMed ID: 10572576
[No Abstract] [Full Text] [Related]
13. Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts.
Itatsu K; Zen Y; Yamaguchi J; Ohira S; Ishikawa A; Ikeda H; Sato Y; Harada K; Sasaki M; Sasaki M; Sakamoto H; Nagino M; Nimura Y; Ohta T; Nakanuma Y
Hum Pathol; 2008 May; 39(5):710-9. PubMed ID: 18329694
[TBL] [Abstract][Full Text] [Related]
14. [Pathology of cholangiocarcinoma].
Guedj N; Bedossa P; Paradis V
Ann Pathol; 2010 Dec; 30(6):455-63. PubMed ID: 21167432
[TBL] [Abstract][Full Text] [Related]
15. The concept of perihilar cholangiocarcinoma is valid.
Ebata T; Kamiya J; Nishio H; Nagasaka T; Nimura Y; Nagino M
Br J Surg; 2009 Aug; 96(8):926-34. PubMed ID: 19591162
[TBL] [Abstract][Full Text] [Related]
16. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
Iguchi T; Aishima S; Taketomi A; Nishihara Y; Fujita N; Sanefuji K; Sugimachi K; Yamashita Y; Maehara Y; Tsuneyoshi M
Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624
[TBL] [Abstract][Full Text] [Related]
17. [An analysis on prognostic factors of hilar cholangiocarcinoma].
Zhou LX; Zhang ZW; Xu ZY
Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1275-7. PubMed ID: 19595185
[TBL] [Abstract][Full Text] [Related]
18. Prognosis and treatment of bile duct carcinoma.
Chung C; Bautista N; O'Connell TX
Am Surg; 1998 Oct; 64(10):921-5. PubMed ID: 9764692
[TBL] [Abstract][Full Text] [Related]
19. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.
Riener MO; Vogetseder A; Pestalozzi BC; Clavien PA; Probst-Hensch N; Kristiansen G; Jochum W
Hum Pathol; 2010 Nov; 41(11):1558-65. PubMed ID: 20621328
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
